Skip to content
Open access · CC-BY via OpenAlex

The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20‐year dementia risk

Michael R. Duggan, Clare Paterson, Yifei Lü, Hannah Biegel, Heather E. Dark, Jenifer Cordon, Murat Bilgel, Naoto Kaneko, Masaki Shibayama, Shintaro Kato, Makio Furuichi, Iwao Waga, Keita Hiraga, Masahisa Katsuno, Yukiko Nishita

Alzheimer s & Dementia · 2025 · ▲ 11 citations

Abstract

INTRODUCTION: There is an unmet need for tools to quantify dementia risk during its multi-decade preclinical/prodromal phase, given that current biomarkers predict risk over shorter follow-up periods and are specific to Alzheimer's disease. METHODS: Using high-throughput proteomic assays and machine learning techniques in the Atherosclerosis Risk in Communities study (n = 11,277), we developed the Dementia SomaSignal Test (dSST). RESULTS: In addition to outperforming existing plasma biomarkers, the dSST predicted mid-life dementia risk over a 20-year follow-up across two independent cohorts with different ethnic backgrounds (areas under the curve [AUCs]: dSST 0.68-0.70, dSST+age 0.75-0.81). In a separate cohort, the dSST was associated with longitudinal declines across multiple cognitive domains, accelerated brain atrophy, and elevated measures of neuropathology (as evidenced by positron emission tomography and plasma biomarkers). DISCUSSION: The dSST is a cost-effective, scalable, and minimally invasive protein-based prognostic aid that can quantify risk up to two decades before dementia onset. HIGHLIGHTS: The Dementia SomaSignal Test (dSST) predicts 20-year dementia risk across two independent cohorts. dSST outperforms existing plasma biomarkers in predicting multi-decade dementia risk. dSST predicts cognitive decline and accelerated brain atrophy in a third cohort. dSST is a prognostic aid that can predict dementia risk over two decades.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1002/alz.14549
Canonical
link ↗
Fetched
2026-11-16 MST

Cite this

APA
Duggan, M.R., Paterson, C., Lü, Y., Biegel, H., Dark, H.E., Cordon, J., Bilgel, M., Kaneko, N., Shibayama, M., Kato, S., Furuichi, M., Waga, I., Hiraga, K., Katsuno, M., Nishita, Y., Otsuka, R., Davatzikos, C.A., Erus, G., Loupy, K.M., &amp; Simpson, M. (2025). The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20‐year dementia risk. <em>Alzheimer s & Dementia</em>. https://doi.org/10.1002/alz.14549
Vancouver
Duggan MR, Paterson C, Lü Y, Biegel H, Dark HE, Cordon J, et al. The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20‐year dementia risk. Alzheimer s & Dementia. 2025. doi:10.1002/alz.14549.
BibTeX
@article{michael2025TheDem, title = {The Dementia SomaSignal Test (dSST): A plasma proteomic predictor of 20‐year dementia risk}, author = {Michael R. Duggan and Clare Paterson and Yifei Lü and Hannah Biegel and Heather E. Dark and Jenifer Cordon and Murat Bilgel and Naoto Kaneko and Masaki Shibayama and Shintaro Kato and Makio Furuichi and Iwao Waga and Keita Hiraga and Masahisa Katsuno and Yukiko Nishita and Rei Otsuka and Christos A. Davatzikos and Güray Erus and Kelsey M. Loupy and Melissa Simpson and Alexandria Lewis and Abhay Moghekar and Priya Palta and Rebecca F. Gottesman and Susan M. Resnick}, journal = {Alzheimer s & Dementia}, year = {2025}, doi = {10.1002/alz.14549}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings